Lineage Cell Therapeutics
LCTX
#8564
Rank
C$0.38 B
Marketcap
C$1.53
Share price
-0.45%
Change (1 day)
-8.52%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -C$31.52 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$14.77 Million. In 2025 the company made an earning of -C$30.22 Million a decrease over its 2024 earnings that were of -C$29.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$31.52 Million4.29%
2025 -C$30.22 Million1.4%
2024 -C$29.81 Million-13.16%
2023 -C$34.32 Million9.83%
2022 -C$31.25 Million-54.24%
2021 -C$68.29 Million86.07%
2020 -C$36.7 Million-31.97%
2019 -C$53.95 Million-5.42%
2018 -C$57.04 Million1.1%
2017 -C$56.42 Million-31.06%
2016 -C$81.83 Million-10.38%
2015 -C$91.31 Million29.69%
2014 -C$70.41 Million31.68%
2013 -C$53.47 Million
2011 -C$25.95 Million89.78%
2010 -C$13.68 Million206.06%
2009 -C$4.47 Million-0.58%
2008 -C$4.5 Million164.89%
2007 -C$1.7 Million-30.22%
2006 -C$2.44 Million
2002 -C$2.83 Million-41.04%
2001 -C$4.79 Million-32.04%
2000 -C$7.05 Million-11.85%
1999 -C$8 Million
1997 -C$5.14 Million12.12%
1996 -C$4.58 Million106.25%
1995 -C$2.23 Million-11.11%
1994 -C$2.5 Million50%
1993 -C$1.67 Million20%
1992 -C$1.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 555.55%๐Ÿ‡บ๐Ÿ‡ธ USA